HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction
Hyo Jin Kang(Georgetown University), Insoo Bae(Georgetown University)
Cited by 59
Related Papers
Inhibition of the <scp>PI</scp>3K/<scp>AKT</scp> pathway potentiates cytotoxicity of <scp>EGFR</scp> kinase inhibitors in triple‐negative breast cancer cells
|Journal of Cellular and Molecular Medicine|2013|77
CR6-interacting Factor 1 (CRIF1) Regulates NF-E2-related Factor 2 (NRF2) Protein Stability by Proteasome-mediated Degradation
|Journal of Biological Chemistry|2010|70
Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine
|International Journal of Oncology|2013|63
BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cells
|International Journal of Oncology|2012|35